07/01/2025
7:02 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
3:45 PM | PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:45 PM | Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:45 PM | Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
3:45 PM | Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:57 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
2:20 PM | ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
3:36 PM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
3:19 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
5:06 AM | Verrica Pharmaceuticals (Filer)
| Form DEFR14A | |
04/22/2025
6:15 AM | Verrica Pharmaceuticals (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for VRCA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/22/2025
6:18 AM | Verrica Pharmaceuticals (Filer)
| Form DEFA14A | |
04/22/2025
6:20 AM | Verrica Pharmaceuticals (Filer)
| Form ARS | |
04/02/2025
3:31 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
3:31 PM | Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2025
3:32 PM | Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:08 AM | Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2025
6:10 AM | Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
11:15 PM | Verrica Pharmaceuticals (Filer)
| Form EFFECT | |
03/18/2025
5:45 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:45 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:05 PM | Verrica Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/11/2025
3:23 PM | Verrica Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
4:01 PM | ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/09/2024
5:22 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/09/2024
4:17 PM | Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/09/2024
4:18 PM | Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
3:55 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/21/2024
3:53 PM | Verrica Pharmaceuticals (Filer)
| Form 424B5 | |
11/20/2024
4:06 PM | Verrica Pharmaceuticals (Filer)
| Form 424B5 | |
11/20/2024
4:08 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:32 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
7:59 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:02 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
8:03 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:04 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:11 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:17 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:15 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:37 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
A grave, grave error. (Ad) Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history.
But one analyst who predicted the collapse of Fannie Mae and GM says the AI giant is now headed for a brutal crash… and it could hit as soon as this year. Watch his urgent Nvidia exposé before it’s too late |
09/27/2024
3:15 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:15 PM | Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:50 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:45 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:35 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:31 PM | Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:17 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:08 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
6:56 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:07 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
5:10 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:11 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:12 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:13 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
